We are pioneers in understanding and utilising the functionality of bacteria as a revolutionary new class of medicines – called live biotherapeutics.
We understand that bacteria which colonise the human body – known as the microbiome – have a key function in health and disease. More than just aiding in the digestion of food and production of vitamins; they play an important role in the regulation of our immune system. We are also forging an understanding of their role in the maintenance of our central nervous system.
These extensive interactions with the human body mean that live biotherapeutics are not just limited to the treatment of gastrointestinal conditions such as IBS and Crohn’s Disease. We have also identified bacteria that are potentially safe and efficacious therapies for diseases such as cancer, asthma, autism and autoimmune conditions such as rheumatoid arthritis and multiple sclerosis.
4D pharma’s approach has the potential to transform treatment for many patients.